Immunotherapy

"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.

Descriptor ID	D007167
MeSH Number(s)	E02.095.465.425
Concept/Terms	Immunotherapy Immunotherapy Immunotherapies

Below are MeSH descriptors whose meaning is more general than "Immunotherapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Biological Therapy [E02.095]
Immunomodulation [E02.095.465]
Immunotherapy [E02.095.465.425]

Below are MeSH descriptors whose meaning is related to "Immunotherapy".

Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.

Bar chart showing 124 publications over 24 distinct years, with a maximum of 12 publications in 2019 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2002	2	0	2
2003	1	0	1
2005	1	0	1
2006	1	3	4
2007	4	0	4
2008	1	3	4
2009	1	1	2
2010	1	1	2
2011	3	1	4
2012	4	1	5
2013	0	3	3
2014	4	2	6
2015	6	3	9
2016	3	6	9
2017	4	3	7
2018	1	2	3
2019	7	5	12
2020	4	7	11
2021	9	3	12
2022	1	3	4
2023	0	5	5
2024	3	2	5
2025	4	4	8

Below are the most recent publications written about "Immunotherapy" by people in Profiles.

Cosgrove CM, Zamarin D, Conejo-Garcia JR, Hacker KE, Vargas R, Konstantinopoulos PA, Mahdi HS, Gaillard S, Markovina S, Kohn EC, Adams SF. A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era. J Natl Cancer Inst. 2025 Sep 01; 117(9):1774-1783.

View in: PubMed
Aare M, Lazarte JMS, Muthu M, Rishi AK, Singh M. Genetically bio-engineered PD-L1 targeted exosomes for immunotherapy of resistant triple negative breast cancer. Drug Deliv Transl Res. 2026 Feb; 16(2):693-710.

View in: PubMed
Wamba BEN, Mondal T, Freenor V F, Shaheed M, Pang O, Bedinger D, Legembre P, Devel L, Bhatnagar S, Leiserowitz GS, Tushir-Singh J. Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. Nat Commun. 2025 Jul 01; 16(1):5748.

View in: PubMed
Akbari B, Hasan MM, Islam SM. Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances. J Drug Target. 2025 Nov; 33(9):1555-1574.

View in: PubMed
Wolf DM, Yau C, Campbell M, Glas A, Barcaru A, Mittempergher L, Kuilman M, Brown-Swigart L, Hirst G, Basu A, Magbanua M, Sayaman R, Huppert L, Delson A, Symmans WF, Borowsky A, Pohlmann P, Rugo H, Clark A, Yee D, DeMichele A, Perlmutter J, Petricoin EF, Chien J, Stringer-Reasor E, Shatsky R, Liu M, Han H, Soliman H, Isaacs C, Nanda R, Hylton N, Pusztai L, Esserman L, van 't Veer L. Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial. JCO Precis Oncol. 2025 Jun; 9:e2400776.

View in: PubMed
Kolawole OP, Pramanik A, Kasani-Akula P, Rai S, Janorkar S, Edorodion Z, Gates K, Kundu S, Ray PC. Multifunctional Nanoplatform for Highly Accurate Profiling of Triple-Negative Breast Cancer-Derived Chemo- and Immunotherapy Resistance Exosomes. ACS Appl Bio Mater. 2025 Jul 21; 8(7):5959-5969.

View in: PubMed
Finati M, Cirulli GO, Chiarelli G, Stephens A, Tinsley S, Morrison C, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Bettocchi C, Carrieri G, Rogers C, Abdollah F. The Role of Cytoreductive Nephrectomy in Contemporary Metastatic Renal Cell Carcinoma: An Other-Cause Mortality Match Population-Based Study. Clin Genitourin Cancer. 2025 Aug; 23(4):102374.

View in: PubMed
Xiong Z, Sneiderman CT, Kuminkoski CR, Reinheimer J, Schwegman L, Sever RE, Habib A, Hu B, Agnihotri S, Rajasundaram D, Zinn PO, Forsthuber TG, Pollack IF, Li X, Raphael I, Kohanbash G. Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy. Genes Immun. 2025 Jun; 26(3):190-199.

View in: PubMed
Mel?ndez-V?zquez NM, Gomez-Manzano C, Godoy-Vitorino F. Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas. Viruses. 2024 11 14; 16(11).

View in: PubMed
Chen S, Liu F, Fu Y, Deng CK, Borgia JA, Ayman AG, Nasu M, Jijiwa M, Yang H, Gong T, Wang J, Ling Z, Wang X, Wang H, Chu Q, Deng Y. A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer. Mol Cancer. 2024 Nov 06; 23(1):247.

View in: PubMed

People

Explore

Similar Concepts

Top Journals